Aspirin May Lower Liver Cancer Risk
Aspirin use has long been linked to heart health, as well as many other positive health benefits. Now liver disease prevention can be added to the list. A new study from the National Cancer Institute has found that aspirin users were 41% less likely to develop liver cancer and 45% less likely to die from chronic liver disease.
But scientists caution that the use of aspirin and other non-steroidal anti-inflammatory drugs-- which come with a risk of bleeding—may not make sense as a strategy for avoiding liver cancer. First, it’s a relatively rare condition. Also, its causes are well-known—such as hepatitis B, hepatitis C and alcohol abuse. So there are other ways to reduce liver cancer risks without taking an aspirin a day solely for that purpose.